Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Short term Debt (2019)

Immunocore Holdings (IMCR) has disclosed Short term Debt for 1 consecutive years, with $24.6 million as the latest value for Q4 2019.

  • Quarterly Short term Debt changed N/A to $24.6 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $24.6 million through Dec 2019, changed N/A year-over-year, with the annual reading at $24.6 million for FY2019, N/A changed from the prior year.
  • Short term Debt hit $24.6 million in Q4 2019 for Immunocore Holdings.
  • In the past five years, Short term Debt ranged from a high of $24.6 million in Q4 2019 to a low of $24.6 million in Q4 2019.